Oxford BioMedica provided capital expenditure guidance for the year 2015/2016. For the year, the company expected capital expenditure to be in the range of £20 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
326 GBX | +0.77% | +2.68% | +48.18% |
May. 09 | Avon Protection wins UK MoD supply deal; Molten Ventures up | AN |
May. 09 | Molten Ventures wins UK MoD supply contract | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.18% | 411M | |
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- OXB Stock
- News Oxford Biomedica plc
- Oxford BioMedica Provides Capital Expenditure Guidance for the Year 2015/2016